1887

Abstract

is the most common cause of antibiotic-associated diarrhoea worldwide. Over the past 10 years, the incidence and severity of disease have increased in North America and Europe due to the emergence of a hypervirulent clone designated PCR ribotype 027. In this study, we sought to identify phenotypic differences among a collection of 26 presumed PCR ribotype 027 strains from the US and the UK isolated between 1988 and 2008 and also re-evaluated the PCR ribotype. We demonstrated that some of the strains typed as BI by restriction endonuclease analysis, and presumed to be PCR ribotype 027, were in fact other PCR ribotypes such as 176, 198 and 244 due to slight variation in banding pattern compared to the 027 strains. The reassigned 176, 198 and 244 ribotype strains were isolated in the US between 2001 and 2004 and appeared to have evolved recently from the 027 lineage. In addition, the UK strains were more motile and more resistant to most of the antibiotics compared to the US counterparts. We conclude that there should be a heightened awareness of newly identified PCR ribotypes such as 176, 198 and 244, and that they may be as problematic as the notorious 027 strains.

  • This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.036194-0
2012-01-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jmm/61/1/49.html?itemId=/content/journal/jmm/10.1099/jmm.0.036194-0&mimeType=html&fmt=ahah

References

  1. Bartlett J. G. 1994; Clostridium difficile: history of its role as an enteric pathogen and the current state of knowledge about the organism. Clin Infect Dis 18:Suppl. 4S265–S272 [View Article][PubMed]
    [Google Scholar]
  2. Brazier J. S., Raybould R., Patel B., Duckworth G., Pearson A., Charlett A., Duerden B. I. HPA Regional Microbiology Network 2008; Distribution and antimicrobial susceptibility patterns of Clostridium difficile PCR ribotypes in English hospitals, 2007-08. Euro Surveill 13:pii:19000[PubMed]
    [Google Scholar]
  3. Calabi E., Fairweather N. 2002; Patterns of sequence conservation in the S-layer proteins and related sequences in Clostridium difficile . J Bacteriol 184:3886–3897 [View Article][PubMed]
    [Google Scholar]
  4. CLSI 2008; Performance Standards for Antimicrobial Susceptibility Testing; 18th Informational Supplement. M100-S18. Wayne, PA: Clinical and Laboratory Standards Institute;
  5. Delaney J. A., Dial S., Barkun A., Suissa S. 2007; Antimicrobial drugs and community-acquired Clostridium difficile-associated disease, UK. Emerg Infect Dis 13:761–763[PubMed] [CrossRef]
    [Google Scholar]
  6. Drudy D., Quinn T., O’Mahony R., Kyne L., O’Gaora P., Fanning S. 2006; High-level resistance to moxifloxacin and gatifloxacin associated with a novel mutation in gyrB in toxin-A-negative, toxin-B-positive Clostridium difficile . J Antimicrob Chemother 58:1264–1267 [View Article][PubMed]
    [Google Scholar]
  7. Eckert C., Vromman F. O., Halkovich A., Barbut F. 2011; Multilocus variable-number tandem repeat analysis: a helpful tool for subtyping French Clostridium difficile PCR ribotype 027 isolates. J Med Microbiol 60:1088–1094 [View Article][PubMed]
    [Google Scholar]
  8. Feuillet V., Medjane S., Mondor I., Demaria O., Pagni P. P., Galán J. E., Flavell R. A., Alexopoulou L. 2006; Involvement of Toll-like receptor 5 in the recognition of flagellated bacteria. Proc Natl Acad Sci U S A 103:12487–12492 [View Article][PubMed]
    [Google Scholar]
  9. Goorhuis A. V. K. T., Van der Kooi T., Vaessen N., Dekker F. W., Van den Berg R., Harmanus C., van den Hof S., Notermans D. W., Kuijper E. J. 2007; Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands. Clin Infect Dis 45:695–703 [View Article][PubMed]
    [Google Scholar]
  10. Griffiths D., Fawley W., Kachrimanidou M., Bowden R., Crook D. W., Fung R., Golubchik T., Harding R. M., Jeffery K. J. other authors 2010; Multilocus sequence typing of Clostridium difficile . J Clin Microbiol 48:770–778 [View Article][PubMed]
    [Google Scholar]
  11. He M., Sebaihia M., Lawley T. D., Stabler R. A., Dawson L. F., Martin M. J., Holt K. E., Seth-Smith H. M., Quail M. A. other authors 2010; Evolutionary dynamics of Clostridium difficile over short and long time scales. Proc Natl Acad Sci U S A 107:7527–7532 [View Article][PubMed]
    [Google Scholar]
  12. Hennequin C., Janoir C., Barc M. C., Collignon A., Karjalainen T. 2003; Identification and characterization of a fibronectin-binding protein from Clostridium difficile . Microbiology 149:2779–2787 [View Article][PubMed]
    [Google Scholar]
  13. Howard S. L., Jagannathan A., Soo E. C., Hui J. P., Aubry A. J., Ahmed I., Karlyshev A., Kelly J. F., Jones M. A. other authors 2009; Campylobacter jejuni glycosylation island important in cell charge, legionaminic acid biosynthesis, and colonization of chickens. Infect Immun 77:2544–2556 [View Article][PubMed]
    [Google Scholar]
  14. Hubert B. L. V., Loo V. G., Bourgault A. M., Poirier L., Dascal A., Fortin E., Dionne M., Lorange M. 2007; A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Québec. Clin Infect Dis 44:238–244 [View Article][PubMed]
    [Google Scholar]
  15. Hussain H. A., Roberts A. P., Mullany P. 2005; Generation of an erythromycin-sensitive derivative of Clostridium difficile strain 630 (630Δ▵erm) and demonstration that the conjugative transposon Tn916ΔE enters the genome of this strain at multiple sites. J Med Microbiol 54:137–141 [View Article][PubMed]
    [Google Scholar]
  16. Jagai J., Naumova E. 2009; Clostridium difficile-associated disease in the elderly, United States. Emerg Infect Dis 15:343–344 [View Article][PubMed]
    [Google Scholar]
  17. Just I., Wilm M., Selzer J., Rex G., von Eichel-Streiber C., Mann M., Aktories K. 1995; The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. J Biol Chem 270:13932–13936 [View Article][PubMed]
    [Google Scholar]
  18. Just I., Hofmann F., Genth H., Gerhard R. 2001; Bacterial protein toxins inhibiting low-molecular-mass GTP-binding proteins. Int J Med Microbiol 291:243–250 [View Article][PubMed]
    [Google Scholar]
  19. Killgore G., Thompson A., Johnson S., Brazier J., Kuijper E., Pepin J., Frost E. H., Savelkoul P., Nicholson B. other authors 2008; Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing. J Clin Microbiol 46:431–437 [View Article][PubMed]
    [Google Scholar]
  20. Kuijper E. J., Coignard B., Brazier J. S., Suetens C., Drudy D., Wiuff C., Pituch H., Reichert P., Schneider F. other authors 2007; Update of Clostridium difficile-associated disease due to PCR ribotype 027 in Europe. Euro Surveill 12:E1–E2[PubMed]
    [Google Scholar]
  21. Lee A., O’Rourke J. L., Barrington P. J., Trust T. J. 1986; Mucus colonization as a determinant of pathogenicity in intestinal infection by Campylobacter jejuni: a mouse cecal model. Infect Immun 51:536–546[PubMed]
    [Google Scholar]
  22. Loo V. G. P. L., Poirier L., Miller M. A., Oughton M., Libman M. D., Michaud S., Bourgault A. M., Nguyen T., Frenette C. other authors 2005; A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 353:2442–2449 [View Article][PubMed]
    [Google Scholar]
  23. Lyras D., Adams V., Lucet I., Rood J. I. 2004; The large resolvase TnpX is the only transposon-encoded protein required for transposition of the Tn4451/3 family of integrative mobilizable elements. Mol Microbiol 51:1787–1800 [View Article][PubMed]
    [Google Scholar]
  24. Milton D. L., O’Toole R., Horstedt P., Wolf-Watz H. 1996; Flagellin A is essential for the virulence of Vibrio anguillarum . J Bacteriol 178:1310–1319[PubMed]
    [Google Scholar]
  25. Mooney H. 2007; Annual incidence of MRSA falls in England, but C. difficile continues to rise. BMJ 335:958 [View Article][PubMed]
    [Google Scholar]
  26. Morris A. M., Jobe B. A., Stoney M., Sheppard B. C., Deveney C. W., Deveney K. E. 2002; Clostridium difficile colitis: an increasingly aggressive iatrogenic disease?. Arch Surg 137:1096–1100 [View Article][PubMed]
    [Google Scholar]
  27. Moulton R. C., Montie T. C. 1979; Chemotaxis by Pseudomonas aeruginosa . J Bacteriol 137:274–280[PubMed]
    [Google Scholar]
  28. Nyč O., Pituch H., Matějková J., Obuch-Woszczatynski P., Kuijper E. J. 2011; Clostridium difficile PCR ribotype 176 in the Czech Republic and Poland. Lancet 377:1407 [View Article][PubMed]
    [Google Scholar]
  29. Pépin J., Valiquette L., Cossette B. 2005; Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 173:1037–1042 [View Article][PubMed]
    [Google Scholar]
  30. Popoff M. R., Rubin E. J., Gill D. M., Boquet P. 1988; Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain. Infect Immun 56:2299–2306[PubMed]
    [Google Scholar]
  31. Pruckler J. M., Benson R. F., Moyenuddin M., Martin W. T., Fields B. S. 1995; Association of flagellum expression and intracellular growth of Legionella pneumophila . Infect Immun 63:4928–4932[PubMed]
    [Google Scholar]
  32. Redelings M. D., Sorvillo F., Mascola L. 2007; Increase in Clostridium difficile-related mortality rates, United States, 1999-2004. Emerg Infect Dis 13:1417–1419[PubMed] [CrossRef]
    [Google Scholar]
  33. Ricciardi R., Rothenberger D. A., Madoff R. D., Baxter N. N. 2007; Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg 142:624–631, discussion 631 [View Article][PubMed]
    [Google Scholar]
  34. Rupnik M., Avesani V., Janc M., von Eichel-Streiber C., Delmée M. 1998; A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J Clin Microbiol 36:2240–2247[PubMed]
    [Google Scholar]
  35. Sebaihia M., Wren B. W., Mullany P., Fairweather N. F., Minton N., Stabler R., Thomson N. R., Roberts A. P., Cerdeño-Tárraga A. M. other authors 2006; The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat Genet 38:779–786 [View Article][PubMed]
    [Google Scholar]
  36. Solomon K., Fanning S., McDermott S., Murray S., Scott L., Martin A., Skally M., Burns K., Kuijper E. other authors 2011; PCR ribotype prevalence and molecular basis of macrolide-lincosamide-streptogramin B (MLSB) and fluoroquinolone resistance in Irish clinical Clostridium difficile isolates. J Antimicrob Chemother 66:1976–1982 [View Article][PubMed]
    [Google Scholar]
  37. Stabler R. A., Gerding D. N., Songer J. G., Drudy D., Brazier J. S., Trinh H. T., Witney A. A., Hinds J., Wren B. W. 2006; Comparative phylogenomics of Clostridium difficile reveals clade specificity and microevolution of hypervirulent strains. J Bacteriol 188:7297–7305 [View Article][PubMed]
    [Google Scholar]
  38. Stabler R. A., He M., Dawson L., Martin M., Valiente E., Corton C., Lawley T. D., Sebaihia M., Quail M. A. other authors 2009; Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biol 10:R102 [View Article][PubMed]
    [Google Scholar]
  39. Tasteyre A., Barc M. C., Collignon A., Boureau H., Karjalainen T. 2001; Role of FliC and FliD flagellar proteins of Clostridium difficile in adherence and gut colonization. Infect Immun 69:7937–7940 [View Article][PubMed]
    [Google Scholar]
  40. van den Berg R. J., Schaap I., Templeton K. E., Klaassen C. H., Kuijper E. J. 2007; Typing and subtyping of Clostridium difficile isolates by using multiple-locus variable-number tandem-repeat analysis. J Clin Microbiol 45:1024–1028 [View Article][PubMed]
    [Google Scholar]
  41. Waligora A. J., Hennequin C., Mullany P., Bourlioux P., Collignon A., Karjalainen T. 2001; Characterization of a cell surface protein of Clostridium difficile with adhesive properties. Infect Immun 69:2144–2153 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.036194-0
Loading
/content/journal/jmm/10.1099/jmm.0.036194-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error